skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Springer Nature - Complete Springer Journals remover tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
455 Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumor models in vivo
455 Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumor models in vivo
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

455 Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumor models in vivo

Oberg, Fredrik ; Bhoi, Sujata ; Jensen, Malene ; Morris, Tom ; Tunblad, Karin ; Wallberg, Hans

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A475-A475 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
2
792 Natural killer T cell immunotherapy combined with fusogenic oncolytic virus and PD-1 blockade enhances survival in a mouse model of spontaneous lung adenocarcinoma
792 Natural killer T cell immunotherapy combined with fusogenic oncolytic virus and PD-1 blockade enhances survival in a mouse model of spontaneous lung adenocarcinoma
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

792 Natural killer T cell immunotherapy combined with fusogenic oncolytic virus and PD-1 blockade enhances survival in a mouse model of spontaneous lung adenocarcinoma

Lukacs, Jordan

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A825-A825 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
3
1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors
1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors

Salek-Ardakani, Shahram ; DiRaimondo, Thomas ; Budimir, Natalija ; Ma, Lina ; Shenhav, Simon ; Cicchini, Vanessa ; Wu, Hua ; Jocic, Renee ; Roup, Fabrece ; Cambell, Calvin ; Caffaro, Carolina ; Aerni, Hans ; Eskiocak, Ugur ; Godfrey, Wayne ; Winter, Charles ; Nasoff, Marc ; Gibson, Neil ; Campbell, David

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1167-A1167 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
211 Chemical priming of natural killer cells for cancer immunotherapy
211 Chemical priming of natural killer cells for cancer immunotherapy
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

211 Chemical priming of natural killer cells for cancer immunotherapy

Choi, Seung Hee ; Eun-Su, Ko ; Joo Dong Park ; Kyung-Soon Park

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A225-A225 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
5
1106 HZ-S506, a selective and orally bioavailable HPK1 degrader, is efficacious as a single agent or in combination with PD-1 antibody
1106 HZ-S506, a selective and orally bioavailable HPK1 degrader, is efficacious as a single agent or in combination with PD-1 antibody
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

1106 HZ-S506, a selective and orally bioavailable HPK1 degrader, is efficacious as a single agent or in combination with PD-1 antibody

Wu, Yizhe ; Zhou, Xinglu ; Jin, Tingting ; Jin, Xinxin

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1149-A1149 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
6
449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6-415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumors
449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6-415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumors
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6-415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumors

Hall, Brett ; Travesa, Anna ; Yamamura, Amy ; Axel, Amy ; Kolitz, Sarah ; Funt, Jason ; Fowler, Kevin ; Nord, Matthew ; Nair, Praveen ; Barrett, Scott ; Zeskind, Benjamin ; King, Peter

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A469-A469 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
7
820 Linear DNA amplicons as a novel antiviral and cancer vaccine strategy
820 Linear DNA amplicons as a novel antiviral and cancer vaccine strategy
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

820 Linear DNA amplicons as a novel antiviral and cancer vaccine strategy

Aurisicchio, Luigi ; Conforti, Antonella ; Compagnone, Mirco ; Salvatori, Erika ; Lione, Lucia ; Pinto, Eleonora ; Shorrock, Clay ; Hayward, James ; Viscount, Brian ; Palombo, Fabio ; Sun, Yuhua ; Liang, Ben Minghwa

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A856-A856 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
8
1226 NCG-hIL15 humanized mice – an excellent model for human immune reconstitution of NK cells
1226 NCG-hIL15 humanized mice – an excellent model for human immune reconstitution of NK cells
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

1226 NCG-hIL15 humanized mice – an excellent model for human immune reconstitution of NK cells

Liu, Xing ; Wu, Meirong ; Wang, Huiyi ; Yu, Weiwei ; Sun, Hongyan ; Ju, Cunxiang ; Wang, Hongyu ; Li, Zhiying ; Moore, Mark ; Zhou, Jing ; Gao, Xiang ; Chen, Santi Suryani

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1271-A1271 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
9
505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors
505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors

Anandhan, Swetha ; Goswami, Sangeeta ; Herbrich, Shelley ; Chen, Yulong ; Sharma, Padmanee

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A528-A528 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
10
447 Dual targeting of PD-1 and CTLA-4 synergizes with focal radiation to durably increase survival against glioblastoma
447 Dual targeting of PD-1 and CTLA-4 synergizes with focal radiation to durably increase survival against glioblastoma
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

447 Dual targeting of PD-1 and CTLA-4 synergizes with focal radiation to durably increase survival against glioblastoma

De Martino, Mara ; Daviaud, Camille ; Vanpouille-Box, Claire

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A467-A467 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1.992)
  2. Revistas revisadas por pares (2.001)

Data de Publicação 

De até
Refinar
  1. Antes de1988  (75)
  2. 1988Até1995  (826)
  3. 1996Até2003  (857)
  4. 2004Até2012  (332)
  5. Após 2012  (76)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.970)
  2. Alemão  (190)
  3. Francês  (31)
  4. Italiano  (4)
  5. Russo  (1)
  6. Espanhol  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.